DHFR and cancer: In cancer, however, a permanent response to drug treatments such as AR gene amplification/mutation [64] or DHFR amplification in response to methotrexate [65] cannot be undone when the treatment is withdrawn, or a compensation pathway is activated in the cancer cells.